Refine
Has Fulltext
- yes (23)
Is part of the Bibliography
- yes (23)
Document Type
- Journal article (22)
- Doctoral Thesis (1)
Keywords
- HNSCC (5)
- artificial intelligence (5)
- head and neck cancer (5)
- caloric restriction (3)
- deep learning (3)
- machine learning (3)
- prediction (3)
- ARONJ (2)
- HGF (2)
- Met (2)
- amino acid restriction (2)
- cancer metabolism (2)
- classification (2)
- mass spectrometry (2)
- methionine (2)
- osteonecrosis of the jaw (2)
- osteoradionecrosis (2)
- 2-DG (1)
- 2-deoxy-D-glucose (1)
- AMPK (1)
- Adult (1)
- CBCT (1)
- CD44 (1)
- COPD (1)
- Cephalometry (1)
- Compound 3k (1)
- DASA-58 (1)
- Dysgnathie (1)
- FasL (1)
- Fernröntgenseitenbild (1)
- Head (1)
- Kephalometrie (1)
- Kraniometrie (1)
- L929 (1)
- LC/MS (1)
- MRONJ (1)
- NFκB (1)
- OHIP-49 (1)
- ONJ (1)
- PD-L1 (1)
- PET (1)
- PKM2 (1)
- Rhabdomyosarcoma (1)
- SCCHN (1)
- SLC-family (1)
- SWLS (1)
- Spindle cell (1)
- Surgery (1)
- TNFα (1)
- TPCA1 (1)
- TXNIP (1)
- Volumentomographie (1)
- Warburg effect (1)
- X-ray (1)
- agar diffusion test (1)
- alveolar bone loss (1)
- amino acid (1)
- amino acid transporter (1)
- ampicillin (1)
- antibiotic bone concentration (1)
- antiresorptive drug-related osteonecrosis of the jaw (1)
- apoptosis (1)
- beta-lactam (1)
- bone loss (1)
- cancer (1)
- case report (1)
- cell vitality (1)
- cisplatin (1)
- complications (1)
- computer-aided (1)
- contact inhibition (1)
- craniofacial orthodontics (1)
- design (1)
- donor-site morbidity (1)
- energy restriction (1)
- fibroblast activation protein (1)
- fibula (1)
- free skin grafts (1)
- gingivitis (1)
- glucose restriction (1)
- glycolysis (1)
- graft (1)
- immune therapy (1)
- inflammation (1)
- inhibitor (1)
- intraosseous (1)
- ischemia (1)
- jaw bone (1)
- lateral radiograph (1)
- length of stay (1)
- liquid chromatography/mass spectrometry (1)
- low carb (1)
- low energy metabolism (1)
- lymph node (1)
- malocclusion (1)
- mandible (1)
- mandibular (1)
- manufacturing (CAD/CAM) (1)
- maxillofacial surgery (1)
- medication-related osteonecrosis of the jaw (1)
- metabolomics (1)
- methionine restriction (1)
- model (1)
- molecular imaging (1)
- multicentric (1)
- object detection (1)
- operative planning (1)
- oral health (1)
- oral microbiome (1)
- oral squamous cell carcinoma (1)
- oral-health-related quality of life (1)
- oro-antral communication (1)
- oro-antral fistula (1)
- oroantral fistula (1)
- oropharyngeal carcinoma (1)
- osteocutaneous (1)
- pN1 (1)
- perfusion culture (1)
- periodontitis (1)
- physical examination (1)
- planning (1)
- platelet-rich fibrin (1)
- preoperative (1)
- progression-free survival (1)
- proliferation (1)
- prospective (1)
- pseudocarcinomatous hyperplasia (1)
- quality of life (1)
- radial forearm flap (1)
- radiographic bone loss (1)
- radiotherapy (1)
- reconstruction (1)
- resection (1)
- satisfaction with life (1)
- surgery (1)
- survival (1)
- teeth extraction (1)
- three-dimensional imaging (1)
- tooth extraction (1)
- treatment benefit (1)
Institute
- Klinik und Poliklinik für Mund-, Kiefer- und Plastische Gesichtschirurgie (23)
- Comprehensive Cancer Center Mainfranken (4)
- Pathologisches Institut (3)
- Theodor-Boveri-Institut für Biowissenschaften (3)
- Institut für Hygiene und Mikrobiologie (2)
- Institut für Pharmazie und Lebensmittelchemie (2)
- Medizinische Klinik und Poliklinik II (2)
- Poliklinik für Zahnärztliche Prothetik (2)
- Institut für diagnostische und interventionelle Radiologie (Institut für Röntgendiagnostik) (1)
- Klinik und Poliklinik für Hals-, Nasen- und Ohrenkrankheiten, plastische und ästhetische Operationen (1)
Sonstige beteiligte Institutionen
The enzyme pyruvate kinase M2 (PKM2) plays a major role in the switch of tumor cells from oxidative phosphorylation to aerobic glycolysis, one of the hallmarks of cancer. Different allosteric inhibitors or activators and several posttranslational modifications regulate its activity. Head and neck squamous cell carcinoma (HNSCC) is a common disease with a high rate of recurrence. To find out more about PKM2 and its modulation in HNSCC, we examined a panel of HNSCC cells using real-time cell metabolic analysis and Western blotting with an emphasis on phosphorylation variant Tyr105 and two reagents known to impair PKM2 activity. Our results show that in HNSCC, PKM2 is commonly phosphorylated at Tyrosine 105. Its levels depended on tyrosine kinase activity, emphasizing the importance of growth factors such as EGF (epidermal growth factor) on HNSCC metabolism. Furthermore, its correlation with the expression of CD44 indicates a role in cancer stemness. Cells generally reacted with higher glycolysis to PKM2 activator DASA-58 and lower glycolysis to PKM2 inhibitor Compound 3k, but some were more susceptible to activation and others to inhibition. Our findings emphasize the need to further investigate the role of PKM2 in HNSCC, as it could aid understanding and treatment of the disease.
Head and neck squamous cell carcinoma (HNSCC) is a widespread disease with a low survival rate and a high risk of recurrence. Nowadays, immune checkpoint inhibitor (ICI) treatment is approved for HNSCC as a first-line treatment in recurrent and metastatic disease. ICI treatment yields a clear survival benefit, but overall response rates are still unsatisfactory. As shown in different cancer models, hepatocyte growth factor/mesenchymal–epithelial transition (HGF/Met) signaling contributes to an immunosuppressive microenvironment. Therefore, we investigated the relationship between HGF and programmed cell death protein 1 (PD-L1) expression in HNSCC cell lines. The preclinical data show a robust PD-L1 induction upon HGF stimulation. Further analysis revealed that the HGF-mediated upregulation of PD-L1 is MAP kinase-dependent. We then hypothesized that serum levels of HGF and soluble programmed cell death protein 1 (sPD-L1) could be potential markers of ICI treatment failure. Thus, we determined serum levels of these proteins in 20 HNSCC patients before ICI treatment and correlated them with treatment outcomes. Importantly, the clinical data showed a positive correlation of both serum proteins (HGF and sPD-L1) in HNSCC patient’s sera. Moreover, the serum concentration of sPD-L1 was significantly higher in ICI non-responsive patients. Our findings indicate a potential role for sPD-L1 as a prognostic marker for ICI treatment in HNSCC.
Head and neck squamous cell carcinoma (HNSCC) is known to overexpress a variety of receptor tyrosine kinases, such as the HGF receptor Met. Like other malignancies, HNSCC involves a mutual interaction between the tumor cells and surrounding tissues and cells. We hypothesized that activation of HGF/Met signaling in HNSCC influences glucose metabolism and therefore substantially changes the tumor microenvironment. To determine the effect of HGF, we submitted three established HNSCC cell lines to mRNA sequencing. Dynamic changes in glucose metabolism were measured in real time by an extracellular flux analyzer. As expected, the cell lines exhibited different levels of Met and responded differently to HGF stimulation. As confirmed by mRNA sequencing, the level of Met expression was associated with the number of upregulated HGF-dependent genes. Overall, Met stimulation by HGF leads to increased glycolysis, presumably mediated by higher expression of three key enzymes of glycolysis. These effects appear to be stronger in Met\(^{high}\)-expressing HNSCC cells. Collectively, our data support the hypothesized role of HGF/Met signaling in metabolic reprogramming of HNSCC.